Updates

Get Alerts
April 4, 2025 | PPP Updates
Guideline Updates for the Pharmacologic Management of Obesity
Alyssa E. Pollock, PharmD, BCPS, Assistant Clinical Professor
April 4, 2025 | PPP Updates
Clinical Practice Guideline Updates for the Treatment of Intra-Abdominal Infections
Erin Blalock, Morrigan Dearman, PharmD Candidates 2025, P. Brandon Bookstaver, PharmD, BCIDP, FCCP, FIDSA, Professor & Director of Residency & Fellowship Training
March 26, 2025 | PPP Updates
Donanemab-azbt (Kisunla™): Newly FDA Approved Amyloid Beta-Directed Antibody for the Treatment of Alzheimer’s Disease
Landry J. Kinsey, PharmD Candidate, Soheyla L. Mahdavian, PharmD, BCGP Professor
March 18, 2025 | PPP Updates
Bimekizumab—2023 FDA Novel Drug for Plaque Psoriasis and Psoriatic Arthritis
Kirsten Smith, PharmD
March 18, 2025 | PPP Updates
Expansion of Pneumococcal Conjugate Vaccine (PCV) Recommendations
Michaelyn Moretz, PharmD, PGY-1 Pharmacy Resident, P. Brandon Bookstaver, PharmD, BCIDP, FCCP, FIDSA, Professor & Director of Residency & Fellowship Training
February 18, 2025 | PPP Updates
mRNA-1345: A Newly Approved RSV Vaccine
Rilee Christensen, PharmD, Rachel Foster, PharmD, MBA
February 18, 2025 | PPP Updates
Ibsrela (tenapanor) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome
Traci M. Poole, PharmD, BCACP, BCGP
February 18, 2025 | PPP Updates
Potassium-Competitive Acid Blocker for Erosive and Non-Erosive Esophagitis
Beth Zerr, PharmD, BCACP, Bernadette Cornelison, PharmD, BCPS
February 18, 2025 | PPP Updates
Prucalopride (Motegrity) for the Treatment of Chronic Idiopathic Constipation
Traci M. Poole, Pharm.D., BCACP, BCGP
February 18, 2025 | PPP Updates
Anti-Interleukin (IL) Treatments for Inflammatory Bowel Disease (IBD)
Shubha Bhat, PharmD, MS, FCCP, BCACP
February 4, 2025 | PPP Updates
Shift in U.S. Market for Available Therapies in the Management of Recurrent Clostridioides Difficile Infection
Christian Corriveau, PharmD Candidate, Joe McNamara, PharmD Candidate, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
December 20, 2024 | PPP Updates
Lazertinib Approved for EGFR Mutated Non-Small Cell Lung Cancer
Jill M. Kolesar, PharmD, MS
December 20, 2024 | PPP Updates
Zenocutuzumab-zbco Approved for Non-Small Cell Lung Cancer and Pancreas Cancer with an NRG fusion
Jill M. Kolesar, PharmD, MS
December 18, 2024 | PPP Updates
The Use of Corticosteroids in Sepsis and Septic Shock
Jacqueline Poole, MD, Assistant Professor, Lee Morrow, MD, Msc, FCP, FCCP, FCCM, ATSF, Professor of Medicine, Professor of Pharmacy Practice, Mark Malesker, PharmD, FCCP, FCCP, FCCM, FASHP, BCPS, Professor of Pharmacy Practice, Professor of Medicine
December 18, 2024 | PPP Updates
Doxycycline Post Exposure Prophylaxis for Bacterial Sexually Transmitted Infections
Chiara Huber, PharmD, Rachel Winters, PharmD, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
December 18, 2024 | PPP Updates
Update on the American Diabetes Association’s Pharmacologic Approaches to Glycemic Treatment of Diabetes Mellitus—2024
Christa M. George, PharmD, CDCES, BCACP
December 18, 2024 | PPP Updates
Cefepime/enmetazobactam in the treatment of complicated urinary tract infections or acute pyelonephritis
Conner Correll, PharmD, Madison Price, PharmD, MBA, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
December 18, 2024 | PPP Updates
Expanded FDA Approval for Bedaquiline
Hannah Bischoff, PharmD, Carmen Faulkner-Fennell, PharmD, BCPS, BCIDP, R. Jake Crocker, PharmD
September 25, 2024 | PPP Updates
Corticosteroids in Severe Community-Acquired Pneumonia
Jeffrey C. Macaraeg, MD, Assistant Professor of Medicine, Lee E. Morrow, MD, MSc, FCP, FCCP, FCCM, ATSF, Professor of Medicine, Professor of Pharmacy Practice, Mark A. Malesker, PharmD, FCCP, FCCP, FCCM, FASHP, BCPS, Professor of Pharmacy Practice, Professor of Medicine
September 18, 2024 | PPP Updates
Long-Acting Growth Hormone Products for the Treatment of Growth Hormone Deficiency
Christina M. Polomoff, PharmD, BCACP, BCPS, FASCP, Devra K. Dang, PharmD, BCPS, CDCES, FNAP, Judy T. Chen, PharmD, BCPS, BCACP, CDCES, FNAP
July 24, 2024 | PPP Updates
Update to Guidelines for Nutrition Support in Adult Critically Ill Patients from the American Society for Parenteral and Enteral Nutrition
Sarah J. Miller, PharmD, BCNSP, FASPEN, Professor Emeritus, Sarah S. Nordbeck, PharmD, BCNSP, Nutrition/General Surgery Clinical Pharmacist-Specialist
July 10, 2024 | PPP Updates
Capivasertib Approved in Combination with Fulvestrant for Hormone Receptor Positive Metastatic Breast Cancer with One or More PIK3CA/AKT1/PTEN Alterations
Jill M. Kolesar, PharmD, MS, College of Pharmacy
June 28, 2024 | PPP Updates
New First-Line Role for SGLT2 Inhibitors and Updates across the Spectrum of Heart Failure by Left Ventricular Ejection Fraction
Tien M. H. Ng, Pharm.D., FHFSA, FACC, FCCP, BCPS, Professor of Clinical Pharmacy and Medicine, Samantha L. Yeung, PharmD, MS, BCCP, Assistant Professor of Clinical Pharmacy
June 28, 2024 | PPP Updates
Pivmecillinam: A Newly Approved Penicillin Antibiotic
Julia Keating, PharmD Candidate, Madeline Lemmon, PharmD Candidate, R. Jake Crocker, PharmD, P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCIDP
June 20, 2024 | PPP Updates
Stable Ischemic Heart Disease: A Focus on Novel Therapies for Lipid Management
Sara Salama, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Dejan Landup, PharmD, HF-Cert, Cardiovascular Clinical Pharmacist